Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer

Objectives: We compared outcomes in post-menopausal estrogen receptor-positive (ER+) breast cancer patients treated with neoadjuvant hormonal therapy (NAHT) or neoadjuvant chemotherapy (NACT). Methods: We retrospectively identified post-menopausal women who received either NAHT or NACT for non-metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcus, David M., Switchenko, Jeffrey M., Prabhu, Roshan, O’Regan, Ruth, Zelnak, Amelia, Fasola, Carolina, Mister, Donna, Torres, Mylin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873517/
https://www.ncbi.nlm.nih.gov/pubmed/24409418
http://dx.doi.org/10.3389/fonc.2013.00317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873517/
https://www.ncbi.nlm.nih.gov/pubmed/24409418
http://dx.doi.org/10.3389/fonc.2013.00317

Ejemplares similares